This is a drug monograph from the BSAVA Small Animal Formulary Part A: Canine and Feline. BSAVA members should login for access to the full monograph. Non-members can join BSAVA, buy a Formulary subscription, or buy the printed edition.
BENCH Study Group (1999) The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial. Journal of Veterinary Cardiology1, 7–18
Brown S, Elliott J, Francey T et al. (2013) Consensus recommendations for standard therapy of glomerular disease in dogs. Journal of Veterinary Internal Medicine27, S27–S43
Häggström J, Boswood A, O'Grady M et al. (2008) Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. Journal of Veterinary Internal Medicine22, 1124–1135
Keene BW, Atkins CE, Bonagura JD et al. (2019) ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. Journal of Veterinary Internal Medicine33, 1127–1140
King JN, Gunn-Moore DA, Tasker S et al. (2006) Tolerability and efficacy of benazepril in cats with chronic kidney disease. Journal of Veterinary Internal Medicine20, 1054–1064
O'Grady MR, O'Sullivan ML, Minors SL and Horne R (2009) Efficacy of benazepril hydrochloride to delay the progression of occult dilated cardiomyopathy in Doberman Pinschers. Journal of Veterinary Internal Medicine. 23, 977–983
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
